The Role of CSF Biomarkers in Discriminating Between Cerebral Amyloid Angiopathy and Alzheimer’s Disease Patients: Systematic Review of Clinical Studies

The Role of CSF Biomarkers in Discriminating Between Cerebral Amyloid Angiopathy and Alzheimer’s Disease Patients: Systematic Review of Clinical Studies

Background: Alzheimer disease (AD), the most prevalent cause of dementia, is characterized by cognitive impairments and gradual memory loss. One of the most common neurological disorders affecting older people is cerebral amyloid angiopathy (CAA), which is defined by the buildup of amyloid β (Aβ) pe...

Full description

Saved in:
Bibliographic Details
Main Authors: Zahra Razmkhah, Haideh Mosleh, Komeil Aghazadeh-Habashi, Fatemeh Pouraminaee, Mohammad Samadian, Hadieh Dadras, Mahmood Gorjizad, Mina Dehghani, Kimia Eyvani, Milad Alipour, Mahsa Asadi Anar
Format: Article
Language:English
Published: Guilan University of Medical Sciences 2024-10-01
Series:Caspian Journal of Neurological Sciences
Subjects:
cerebral amyloid angiopathy (caa)
alzheimer disease (ad)
amyloid β (aβ)
cerebrospinal fluid (csf)
Online Access:http://cjns.gums.ac.ir/article-1-713-en.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://cjns.gums.ac.ir/article-1-713-en.pdf

Similar Items